Post Content
Merck says Keytruda injection on par with approved IV version in trial
Merck said a study showed its injectable version of cancer drug Keytruda was not inferior to the currently approved intravenous formulation of its treatment.
News Worldwide
Post Content
Merck said a study showed its injectable version of cancer drug Keytruda was not inferior to the currently approved intravenous formulation of its treatment.
As undersea cables are cut, Finland and Germany say Europe is threated not only bt Russia’s war in Ukraine, but “from hybrid warfare by malicious actors.”